Veru
VERU • NASDAQ
Veru is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mitchell S. Steiner, with a market cap of $33.5M.
CEOMitchell S. Steiner
Next Earnings
Upcoming earnings announcement for Veru
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.32
Earnings History
Past 12 earnings reports for Veru
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | Q1 2026 | -$0.26Est: -$0.53 | +50.9% | - | — | — |
| Dec 17, 2025 | FY 2025 | -$1.55Est: -$1.69 | +8.3% | - | — |  10-K |
| Aug 12, 2025 | Q3 2025 | -$0.50Est: -$0.32 | -56.3% | - | — | 10-Q |
| May 8, 2025 | Q2 2025 | -$0.05Est: -$0.05 | 0.0% | -Est: $3.5M | -100.0% | 10-Q |
| Feb 13, 2025 | Q1 2025 | -$0.07Est: -$0.08 | +12.5% | -Est: $3.0M | -100.0% | 10-Q |
| Dec 16, 2024 | Q4 2024 | -$0.06 | — | $6.7M | — | 10-K |
| Aug 8, 2024 | Q3 2024 | -$0.07Est: -$0.06 | -16.7% | $4.0MEst: $3.5M | +13.0% | 10-Q |
| May 8, 2024 | Q2 2024 | -$0.07Est: -$0.05 | -40.0% | $4.1MEst: $3.0M | +37.8% | 10-Q |
| Apr 1, 2024 | Q1 2024 | -$0.08Est: -$0.13 | +38.5% | $2.1MEst: $5.2M | -58.8% | 10-Q |
| Dec 8, 2023 | Q4 2023 | -$0.27 | — | $3.9M | — | — |
| Aug 10, 2023 | Q3 2023 | -$0.13Est: -$0.20 | +35.0% | $3.3MEst: $10.2M | -67.3% | 10-Q |
| May 11, 2023 | Q2 2023 | -$0.43Est: -$0.33 | -30.3% | $6.6MEst: $4.3M | +52.5% | 10-Q |